Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiographic Changes Following Closed Sinus Augmentation With L-PRF
NCT07836725Phase 1Not yet recruiting
- Sponsor
- UT Health San Antonio
- Start
- Jan 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Platelet-Rich Fibrin in partially edentulous maxilla, sponsored by UT Health San Antonio. Primary endpoints: Maxillary Sinus Volume using 2D imaging at 6 months and Maxillary Sinus Volume using 3D imaging at 6 months. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Platelet-Rich Fibrin
03
Conditions
partially edentulous maxilla
Beyond the preview
Go deeper on NCT07836725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836725.